And if youve already discovered youre pregnant while on semaglutide, the available research suggests reason for cautious optimism
For diabetes-specific data, the completed TRANSCEND-T2D-1 trial (537 patients, 40 weeks) is the relevant source: retatrutide reduced HbA1c by up to 2.0% (9mg dose), with 8289% of patients reaching the 120 bpm at rest) The Unknowns: What We're Still Waiting to Learn Full 2-year published safety data: TRIUMPH-1 104-week extension data is available for the BMI 35 subgroup, but full publication of the complete 2-year dataset is pending expected late 2026
Research demonstrates its remarkable ability to promote healing of muscles, tendons, ligaments, and even the gut lining
Some people have also found relief from skin conditions such as acne after receiving a IV vitamin drip in Birmingham
If you think you may be eligible for Foundayo or another GLP-1 medication, ask your doctor for more guidance.